Literature DB >> 26435499

Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.

Youyi Dai1, Huaxin Duan2, Chaojun Duan3, Rongrong Zhou1, Yuxiang He1, Qingsong Tu1, Liangfang Shen4.   

Abstract

Epigenetic alteration induced loss function of the transcription factor 21 (TCF21) has been associated with different types of human cancers. However, the epigenetic regulation and molecular functions of TCF21 in colorectal cancer (CRC) remain unknown. In this study, TCF21 expression levels and methylation status of its promoter region in CRC cell lines (n = 5) and CRC tissues (n = 151) as well as normal colorectal mucosa (n = 30) were assessed by RTq-PCR and methylation analysis (methylation specific PCR, MSP and bisulfite sequencing PCR, BSP), respectively. The cellular functions of TCF21 on CRC cell proliferation, apoptosis, invasion and migration were investigated in vitro. Our data revealed that TCF21 was frequently silenced by promoter hypermethylation in both tested CRC cell lines and primary CRC, and correlation analysis between methylation status and clinicopathologic parameters found that TCF21 methylation was significantly correlated with lymph node invasion (P = 0.013), while no significant correlation was found in other parameters. In addition, demethylation treatment resulted in re-expression of TCF21 in CRC cell lines, and cellular function experiments revealed that restoration of TCF21 inhibited CRC cell proliferation, promoted apoptosis and suppressed cell invasion and migration, suggesting that TCF21 may function as a tumor suppressor gene, which is downregulated through promoter hypermethylation in CRC development.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Cell invasion; Cell migration; Cell proliferation; Colorectal cancer; DNA methylation; Transcription factor 21 (TCF21)

Mesh:

Substances:

Year:  2015        PMID: 26435499     DOI: 10.1016/j.bbrc.2015.09.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer.

Authors:  Baokun Chen; Chao Zeng; Yiwang Ye; Da Wu; Zhimin Mu; Jixian Liu; Yuancai Xie; Hao Wu
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

2.  CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression.

Authors:  Daishi Chen; Wei Ma; Zhaoyang Ke; Fei Xie
Journal:  Cell Cycle       Date:  2018-09-13       Impact factor: 4.534

3.  CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity.

Authors:  Zhao-Ru Dong; Ai-Wu Ke; Tao Li; Jia-Bing Cai; Ya-Fei Yang; Wei Zhou; Guo-Ming Shi; Jia Fan
Journal:  Mol Cancer       Date:  2021-05-13       Impact factor: 27.401

4.  TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.

Authors:  Saskia L Gooskens; Timothy D Klasson; Hendrik Gremmels; Ive Logister; Robert Pieters; Elizabeth J Perlman; Rachel H Giles; Mary M van den Heuvel-Eibrink
Journal:  Mol Oncol       Date:  2017-12-14       Impact factor: 6.603

5.  Curcumin increases exosomal TCF21 thus suppressing exosome-induced lung cancer.

Authors:  Hao Wu; Jingcheng Zhou; Chao Zeng; Da Wu; Zhimin Mu; Baokun Chen; Yuancai Xie; Yiwang Ye; Jixian Liu
Journal:  Oncotarget       Date:  2016-12-27

6.  TCF21 genetic polymorphisms and breast cancer risk in Chinese women.

Authors:  Xueren Gao; Jiaojiao Yang; Mingxi Wang; Jianqiong Zhang
Journal:  Oncotarget       Date:  2016-08-23

7.  TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling.

Authors:  Youyi Dai; Huaxin Duan; Chaojun Duan; Hong Zhu; Rongrong Zhou; Haiping Pei; Liangfang Shen
Journal:  Onco Targets Ther       Date:  2017-03-14       Impact factor: 4.147

Review 8.  Multiple biological functions of transcription factor 21 in the development of various cancers.

Authors:  Xiaodi Jiang; Zhi Yang
Journal:  Onco Targets Ther       Date:  2018-06-19       Impact factor: 4.147

9.  Prognostic significance of TCF21 mRNA expression in patients with lung adenocarcinoma.

Authors:  Jian Xiao; Aibin Liu; Xiaoxiao Lu; Xi Chen; Wei Li; Shuya He; Bixiu He; Qiong Chen
Journal:  Sci Rep       Date:  2017-05-17       Impact factor: 4.379

10.  H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer.

Authors:  He Liu; Yongmin Li; Jingwen Li; Yanlong Liu; Binbin Cui
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.